Saihari Sadanandan is a Cardiology physician affiliated with St. Joseph's Hospital. OpenAlex indexes 28 publications with 677 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4612 N Habana Ave
2nd Fl
Tampa, FL 336147101
Telephone
813-875-9000Registry record last updated 29 Dec 2016.
Industry payments
46 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Stryker CorporationProgram year20251 payment
- Recor Medical IncProgram year20255 payments
- Novartis Pharmaceuticals CorporationProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.6%Beta blocker18%Metoprolol Succinate56%Carvedilol27%Metoprolol Tartrate12%Bisoprolol Fumarate3%Atenolol3%Part D<11 patientsStatin14%Atorvastatin Calcium71%Rosuvastatin Calcium29%Part D≥93 patients+ 12 more classes in this area
Blood & clotting
21.3%P2Y12 inhibitor14.7%Clopidogrel96%Brilinta4%Part D<11 patientsFactor Xa inhibitor6.6%Eliquis78%Xarelto22%Part D≥42 patientsMetabolism & gastrointestinal
2.1%SGLT2 inhibitor0.9%Farxiga100%Part D<11 patientsPotassium supplement0.7%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and Efficacy of a Novel Sealant‐Based Vascular Closure Device Following Electrophysiology Procedures: ReliaSeal Trial
Journal of Cardiovascular Electrophysiology
2025 - ONE YEAR RESULTS OF THE FLORIDA CARDIOVASCULAR QUALITY NETWORK: AN INNOVATIVE REGISTRY IMPROVES CARDIOVASCULAR RISK IN HIGH RISK HYPERLIPIDEMIA PATIENTS
Journal of the American College of Cardiology
2025 - THE FLORIDA CARDIOVASCULAR QUALITY NETWORK: BASELINE RESULTS OF A LARGE STATEWIDE QUALITY REGISTRY IN HIGH RISK HYPERLIPIDEMIA PATIENTS
Journal of the American College of Cardiology
2024 - Stromal Cell–Derived Factor-1 Plasmid Treatment for Patients With Peripheral Artery Disease (STOP-PAD) Trial: Six-Month Results
Journal of Endovascular Therapy
2020
Similar KOLs
Other experts from the same institution or the same specialty.
James Huhta, MD
St. Joseph's Hospital
John R. Gonder
St. Joseph's Hospital
Franklin Loffer, MD
St. Joseph's Hospital
Benjamin Hendricks, MD
St. Joseph's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”